These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 7940838)
1. Optimal immunosuppressive clinical regimen in liver transplantation. Farges O; Samuel D; Bismuth H Transplant Proc; 1994 Oct; 26(5):2676-8. PubMed ID: 7940838 [No Abstract] [Full Text] [Related]
2. Clinical results of quadruple drug immunosuppression in liver transplantation. Fabregat J; Fradera R; Jaurrieta E; Figueras J; Rafecas A; Rufi G; Casanovas T; Casais L; Gil Vernet S Transplant Proc; 1992 Feb; 24(1):148-9. PubMed ID: 1539217 [No Abstract] [Full Text] [Related]
3. Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection. Fabregat J; Fradera R; Figueras J; Rafecas A; Torras J; Martinez LaCasa J; Baliellas C; Casais L; Jaurrieta E Transplant Proc; 1994 Oct; 26(5):2697-9. PubMed ID: 7940845 [No Abstract] [Full Text] [Related]
4. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation. Chen M; Wade J; Levy GA; Greig PD Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844 [No Abstract] [Full Text] [Related]
5. Incidence and patterns of rejection using different induction therapies in liver transplant recipients. Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835 [No Abstract] [Full Text] [Related]
6. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function. Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289 [No Abstract] [Full Text] [Related]
7. Short- and long-term cyclosporine dosage in liver transplantation. McCaughan GW; Bookallil MJ; Sheil AG Transplant Proc; 1994 Oct; 26(5):2674-5. PubMed ID: 7940837 [No Abstract] [Full Text] [Related]
8. Cyclosporine Neoral in liver transplant recipients. Levy G; Rochon J; Freeman D; Wong PY; Banks L; Roach C; Engel K; Grant D Transplant Proc; 1994 Oct; 26(5):2949-52. PubMed ID: 7940930 [No Abstract] [Full Text] [Related]
9. Five-year experience with a triple drug protocol in renal transplantation. Pallardó LM; Sánchez J; García J; Puig N; Sánchez P; Górriz JL; Cruz JM Transplant Proc; 1992 Feb; 24(1):56-7. PubMed ID: 1539342 [No Abstract] [Full Text] [Related]
10. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group. Grant D; Rochon J; Levy G Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208 [No Abstract] [Full Text] [Related]
11. Cyclosporine levels in the early posttransplant period: predictive of chronic rejection in liver transplantation? Soin AS; Rasmussen A; Jamieson NV; Tokat Y; Watson CJ; Friend PJ; Wight DG; Calne RY Transplant Proc; 1995 Feb; 27(1):1129-30. PubMed ID: 7878821 [No Abstract] [Full Text] [Related]
12. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation. Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180 [No Abstract] [Full Text] [Related]
15. Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease. Mueller AR; Platz KP; Bechstein WO; Blumhardt G; Lobeck H; Hop U; Neuhaus P Transplant Proc; 1994 Dec; 26(6):3637-9. PubMed ID: 7527984 [No Abstract] [Full Text] [Related]
16. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss. Bahra M; Neumann UP; Jacob D; Langrehr JM; Neuhaus P Transplant Proc; 2005 May; 37(4):1700-2. PubMed ID: 15919436 [TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive requirements for small bowel/liver transplantation. McAlister V; Grant D; Wall W; Roy A; Ghent C; Zhong R; Duff J Transplant Proc; 1993 Feb; 25(1 Pt 2):1204-5. PubMed ID: 8442086 [No Abstract] [Full Text] [Related]
18. Late acute rejection in renal transplant recipients: response to steroid treatment. Prieto C; Pulido F; Rodríguez-Paternina E; Algranati C; Bello I; Farias J; G-Millet V Transplant Proc; 1992 Feb; 24(1):35-6. PubMed ID: 1539312 [No Abstract] [Full Text] [Related]
19. Optimal clinical regimens for living related liver transplantation. Malagó M; Rogiers X; Wadström J; Burdelski M; Broelsch CE Transplant Proc; 1994 Oct; 26(5):2665-8. PubMed ID: 7940834 [No Abstract] [Full Text] [Related]
20. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation. Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207 [No Abstract] [Full Text] [Related] [Next] [New Search]